Frontiers in Immunology (Apr 2018)

Autoimmune Lymphoproliferative Syndrome-FAS Patients Have an Abnormal Regulatory T Cell (Treg) Phenotype but Display Normal Natural Treg-Suppressive Function on T Cell Proliferation

  • Fabienne Mazerolles,
  • Fabienne Mazerolles,
  • Marie-Claude Stolzenberg,
  • Marie-Claude Stolzenberg,
  • Olivier Pelle,
  • Olivier Pelle,
  • Capucine Picard,
  • Capucine Picard,
  • Capucine Picard,
  • Capucine Picard,
  • Benedicte Neven,
  • Benedicte Neven,
  • Benedicte Neven,
  • Alain Fischer,
  • Alain Fischer,
  • Alain Fischer,
  • Aude Magerus-Chatinet,
  • Aude Magerus-Chatinet,
  • Frederic Rieux-Laucat,
  • Frederic Rieux-Laucat

DOI
https://doi.org/10.3389/fimmu.2018.00718
Journal volume & issue
Vol. 9

Abstract

Read online

ObjectiveAutoimmune lymphoproliferative syndrome (ALPS) with FAS mutation (ALPS-FAS) is a nonmalignant, noninfectious, lymphoproliferative disease with autoimmunity. Given the central role of natural regulatory T cells (nTregs) in the control of lymphoproliferation and autoimmunity, we assessed nTreg-suppressive function in 16 patients with ALPS-FAS.ResultsThe proportion of CD25highCD127low Tregs was lower in ALPS-FAS patients than in healthy controls. This subset was correlated with a reduced CD25 expression in CD3+CD4+ T cells from ALPS patients and thus an abnormally low proportion of CD25highFOXP3+ Helios+ T cells. The ALPS patients also displayed a high proportion of naïve Treg (FOXP3lowCD45RA+) and an unusual subpopulation (CD4+CD127lowCD15s+CD45RA+). Despite this abnormal phenotype, the CD25highCD127low Tregs’ suppressive function was unaffected. Furthermore, conventional T cells from FAS-mutated patients showed normal levels of sensitivity to Treg suppression.ConclusionAn abnormal Treg phenotype is observed in circulating lymphocytes of ALPS patients. However, these Tregs displayed a normal suppressive function on T effector proliferation in vitro. This is suggesting that lymphoproliferation observed in ALPS patients does not result from Tregs functional defect or T effector cells insensitivity to Tregs suppression.

Keywords